Phase 2 PAVIA Clinical Trial in Non-Proliferative Diabetic Retinopathy (NPDR)

Other Clinical Trials - EYP-1901

Phase 2 DAVIO 2 Clinical Trial Topline Results (Wet AMD)

A Non-inferiority Trial Evaluating Two Doses of EYP-1901 Against an Aflibercept Control in Wet AMD

Phase 2 DAVIO 2 Sub-Group Analysis (Wet AMD)

Patients Anti-VEGF Supplement-Free Up to 6 Months

Phase 2 VERONA Clinical Trial in Diabetic Macular Edema (DME)

Randomized, Open-Label, Aflibercept Controlled Trial with a Single EYP-1901 Injection